Prescription Drug Policy, 2025 And 2026: The Year In Review And The Year Ahead

Forefront Group 2026 Dataset

View at publisher
Authors: Rachel E. Sachs
DOI: 10.1377/forefront.20260105.879360
Cited by: 0

Abstract

Key policy developments in 2025 and 2026 will have critical consequences, not only for patient access, but also for the ability of researchers and pharmaceutical companies to innovate and develop the next generation of scientific breakthroughs.

Publication details

Journal / source
Forefront Group
Publication date
7 January 2026
Document type
Dataset